Chitin-Glucan Ingredient Achieves Novel Food Approval

supps.jpg

09 Mar 2011 --- Artinia is a high-purity, low viscosity, natural ingredient that features the benefits of both soluble and insoluble fibers containing 80% dietary fiber, primarily insoluble.

3/9/2011 --- Stratum Nutrition announces that the European Union Commission has reached a conclusion approving chitin-glucan from Aspergillus niger, branded Artinia, as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council.

On the basis of the extensive scientific assessment, it is established that the ingredient complies with the criteria laid down in Article 3(1) of Regulation (EC) No 258/97. The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health and therefore decides: Chitin-glucan from Aspergillus niger as specified in the Annex may be placed on the market in the European Union as a novel food ingredient to be used in food supplements with a maximum dose of 5 grams per day.

Artinia is a high-purity, low viscosity, natural ingredient that features the benefits of both soluble and insoluble fibers containing 80% dietary fiber, primarily insoluble. Artinia supports healthy arteries, the body’s natural antioxidant systems, and has been shown to reduce the level of oxidized-low density lipoprotein (LDL). Artinia is obtained exclusively from renewable, non-GMO sources and is manufactured in an ISO-9001:2008 certified facility following HACCP method under strict GMP specifications. Artinia is certified Kosher and Halal, gluten-free and hypo-allergenic, and is suitable for use in vegetarian products.

Related Articles

Nutrition & Health News

Diets rich in fish and vegetable oils could reduce epileptic seizures

18 Aug 2017 --- For the first time, production of estrogen in the brain has been directly linked to a study to the presence of docosahexaenoic acid (DHA). The findings of a Hiroshima University study could have implications for treating seizures, as it links DHA directly to a reduction in epileptic seizures.

Nutrition & Health News

Kyowa Hakko’s citicoline supplementation may slow glaucoma

18 Aug 2017 --- A 500mg dose of citicoline from Kyowa Hakko Europe (Kyowa) may significantly slow the progression of visual acuity loss due to glaucoma. This is according to a new study by researchers at the Sao Paolo Hospital Eye Clinic at the University of Milan, who followed 41 patients with progressing glaucoma – a disease that damages the optic nerve and can lead to vision problems and blindness – over two years.

Business News

DuPont expands US probiotics pilot facility to improve NPD, delivery times

18 Aug 2017 --- DuPont Nutrition & Health (DuPont) has announced a “substantial upgrade” to its probiotics pilot facility in Madison, Wisconsin, US. The new enhancements will increase its capability for rapidly developing and commercializing new probiotics with decreased time to market. The US$10 million investment allows for increased pace of new product development and significantly improved delivery times on pilot material for clinical trials and customer evaluations, according to DuPont.

Regulatory News

Cutting calories now “critical” to UK childhood obesity strategy

18 Aug 2017 --- The health agency Public Health England (PHE) has shifted its focus away from solely targeting sugar to cutting excess calorie consumption from all sources in its anti-obesity strategy for children in the UK. “A third of children leave primary school overweight or obese and an excess of calories – not just excess sugar consumption – is the root cause of this,” says Duncan Selbie, Chief Executive of PHE. “We will work with the food companies and retailers to tackle this as the next critical step in combating our childhood obesity problem.”

Nutrition & Health News

Walnuts activate brain area that controls appetite, finds study

17 Aug 2017 --- Consuming walnuts activates an area in the brain associated with regulating hunger and cravings. This is according to a first-of-its-kind new brain imaging study by researchers at Beth Israel Deaconess Medical Center (BIDMC), the findings of which, published online in the journal Diabetes, Obesity and Metabolism, reveal for the first time the neurocognitive impact the nuts have on the brain. 

More Articles
URL : http://www.nutritioninsight.com:80/headlines/Chitin-Glucan-Ingredient-Achieves-Novel-Food-Approval.html